What Aurora Nordic does

Aurora Nordic is the Danish regional subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB), a Canadian-headquartered pharmaceutical-grade medical cannabis producer operating across Europe. The entity is registered in Odense, Denmark and operates as part of the broader "Aurora Europe" division, which runs wholly-owned regional subsidiaries in Germany, Poland, the UK, and Denmark. Aurora Nordic and its sister entities manufacture and distribute medical cannabis products through EU-GMP and GACP compliant production facilities located in Germany, dispensing products to patients via prescription-based access through licensed pharmacies across multiple European jurisdictions.

The company's core technology revolves around pharmaceutical-grade cannabis cultivation and production, including advanced plant genetics, proprietary cultivar development, and breeding techniques developed since 2014. The product portfolio consists of five brands — Aurora Medical (the flagship), Pedanios, IndiMed, Daily Special, and SANRAF — each positioned to address specific patient segments across Europe. Quality assurance processes include consistent testing for purity, potency, and active ingredient content to meet pharmaceutical-grade safety and dosing standards. The business operates a B2B2C model: it engages healthcare professionals (physicians and prescribers) through enterprise field sales and education initiatives, who in turn prescribe Aurora's products to patients, with products ultimately dispensed through licensed pharmacy networks in each regulated market.

Name

Aurora Nordic

Legal name

Aurora Cannabis Inc.

Website

https://auroranordic.dk

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Aurora Nordic is the Danish regional arm of Aurora Cannabis Inc., producing and distributing pharmaceutical-grade medical cannabis through EU-GMP facilities across Europe. It serves patients and healthcare professionals via a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) dispensed through licensed pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Medical Cannabis Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Medical Cannabis Dispensaries (CRANAFAB)

Keywords

• Medical cannabis production
• Pharmaceutical cannabis manufacturing
• EU-GMP cannabis
• Cannabis genetics breeding
• Medical cannabis brands

Headquarters

HQ city

Odense

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Cannabis Product Sales: Sale of pharmaceutical-grade medical cannabis products including flower, oils, and other formulations to patients across Europe through prescription-based access

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Aurora Nordic manufactures and distributes pharmaceutical-grade medical cannabis products (flower, oils, and formulations) in EU-GMP compliant facilities for distribution across European markets. The company operates a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) and sells these products through licensed pharmacies via prescription-based access, supported by direct engagement with prescribing healthcare professionals.

Product overview

Aurora Nordic operates as part of Aurora's European operations, offering a multi-brand portfolio of pharmaceutical-grade medical cannabis products. The portfolio includes Aurora Medical (the primary brand), Pedanios, IndiMed, Daily Special, and SANRAF. The company produces cannabis-based treatments in EU-GMP compliant facilities and offers these brands across multiple European countries to meet patient needs.

Differentiator

Problem solved

Functional benefit

Brands

• Aurora Medical: Medical cannabis brand offering pharmaceutical-grade products
• Pedanios
• IndiMed
• Daily Special
• SANRAF

Products and services

• Aurora Medical Aurora's primary medical cannabis brand offering pharmaceutical-grade cannabis-based treatments, including flower, oils, and other formulations, dispensed via prescription through licensed pharmacies across European markets.
• Pedanios Medical cannabis brand under Aurora's portfolio serving European patients, offering pharmaceutical-grade cannabis-based treatments dispensed via prescription through licensed pharmacies.
• IndiMed Medical cannabis brand offering treatment options for patients in Europe, providing pharmaceutical-grade cannabis-based products through prescription-based access.
• Daily Special Medical cannabis brand within Aurora's European product portfolio, offering pharmaceutical-grade cannabis-based treatments to patients through licensed pharmacies.
• SANRAF Medical cannabis brand offered by Aurora in the European market, providing pharmaceutical-grade cannabis-based treatments through prescription-based dispensing channels.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Copeia - Physicians Experience PlatformcoreStrategic or Co-development PartnerPartnership to advance physician education and experience with medical cannabis, providing resources and platforms for healthcare professionals
• IG Hanf (Interessengemeinschaft Hanf)coreStrategic or Co-development PartnerGerman Cannabis Interest Group partnership to help shape the future of medical cannabis in Germany through industry collaboration
• BPC (Bundescannabisplan)minorStrategic or Co-development PartnerPartnership with leading associations to shape policy and future of medical cannabis in Europe

Scale indicators3 records

Direct peers

• Cannamedical: German medical cannabis distributor and EU-GMP importer supplying pharmacies across Germany. Directly comparable in go-to-market model (pharmacy channel, prescriber engagement) and target product types.
• Demecan: German EU-GMP-certified medical cannabis producer supplying German pharmacies. Direct competitor in Aurora Nordic's largest European market with comparable pharmaceutical-grade positioning.
• STENOCARE: Danish-based medical cannabis producer listed on Nasdaq First North, supplying the Nordic market with prescription-based cannabis oil products. Closest direct competitor given shared Danish base, similar regulatory positioning, and overlapping prescriber channels.
• Bedrocan: Dutch producer of standardized medicinal cannabis flower under EU-GMP, supplying Germany and other European countries. Compares on pharmaceutical-grade standardization, regulatory compliance and pharmacy-led distribution model.

Broad incumbents

• Canopy Growth Corporation: Canadian parent of several European medical cannabis operations (including Spectrum Therapeutics), a broad incumbent with overlapping product categories and EU-GMP positioning. Comparable in target customers and prescription-led model.
• OrganiGram Holdings: Canadian cannabis producer with European medical cannabis ambitions through strategic partnerships and EU-GMP-aligned operations. Broad incumbent in the same pharmaceutical-grade medical cannabis category.
• Aurora Cannabis Inc. Parent company of Aurora Nordic; publicly traded on NASDAQ (ACB) and produces medical cannabis under the same EU-GMP framework, operating across Europe, Canada and globally. Directly comparable in product category, regulatory posture and customer base.
• Tilray Brands: Global cannabis company with significant European medical cannabis footprint in Germany, Portugal and other markets. Broad incumbent with overlapping EU-GMP operations and competing brands targeting the same prescribers.

Regional players

• Little Green Pharma: Australian medical cannabis producer expanding into European markets via distribution agreements. Comparable as an EU-GMP-aligned medical cannabis peer targeting European pharmacy channels, though primarily serving different geographies.

Others

• Cannify: European-focused medical cannabis education and matching platform serving patients and physicians. Adjacent ecosystem participant that complements pharmacy-based distribution models like Aurora Nordic's, supporting physician and patient education.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/aurora_mmj/?lang=en
• LinkedInlinkedin.com/company/aurora-cannabis-inc-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aurora Nordic